Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
53.2M
-
Number of holders
-
95
-
Total 13F shares, excl. options
-
38.2M
-
Shares change
-
+698K
-
Total reported value, excl. options
-
$146M
-
Value change
-
+$3.42M
-
Put/Call ratio
-
0
-
Number of buys
-
50
-
Number of sells
-
-44
-
Price
-
$3.81
Significant Holders of scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (SCPH) as of Q2 2025
115 filings reported holding SCPH - scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share as of Q2 2025.
scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (SCPH) has 95 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 38.2M shares
of 53.2M outstanding shares and own 71.78% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (6.06M shares), Rubric Capital Management LP (4.6M shares), AIGH Capital Management LLC (3.87M shares), KING LUTHER CAPITAL MANAGEMENT CORP (3.54M shares), BlackRock, Inc. (2.21M shares), MORGAN STANLEY (2.15M shares), VANGUARD GROUP INC (1.84M shares), RICE HALL JAMES & ASSOCIATES, LLC (1.47M shares), 5AM Venture Management, LLC (1.2M shares), and Nantahala Capital Management, LLC (995K shares).
This table shows the top 95 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.